Studies on the inhibitory effects of analogues of dapsone on neutrophil function in-vitro

被引:12
作者
Coleman, MD [1 ]
Smith, JK [1 ]
Perris, AD [1 ]
Buck, NS [1 ]
Seydel, JK [1 ]
机构
[1] FORSCHUNGSZENTRUM BORSTEL, ZENTRUM MED & BIOWISSENSCH, D-23845 BORSTEL, GERMANY
关键词
D O I
10.1111/j.2042-7158.1997.tb06752.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have compared twelve sulphone analogues of dapsone in terms of inhibition both of zymosan-mediated human neutrophil respiratory burst and inhibition of interleukin-l-stimulated neutrophil adhesion to transformed human umbilical vein endothelial cells. Overall, there was a good correlation between the respective rank orders of compound potency in the two test systems. The most effective compounds in terms of respiratory burst and adherence inhibition were the 2-nitro-4-amino-, 2-hydroxy-4-aminopropyl-, and 2-methoxy-4-aminoethyl- derivatives. In general, potency was inversely associated with lipophilicity; compounds with bulky side-chains, e.g. the 2-methyl-4-aminopentyl, 2-methyl-4-aminohexyl and the 2-hydroxymethyl-4-aminoethyl derivatives, were less potent. A 2-hydroxy-4-amino- derivative was the exception, however, with low lipophilicity and relatively low potency. All of the compounds tested showed comparable or greater inhibition in both the neutrophil-mediated assays compared with dapsone. Some of the compounds might, because of their good tissue penetration and lower toxicity than dapsone, have the potential to undergo further development.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 25 条
[1]  
AFFORD SC, 1992, J BIOL CHEM, V267, P21612
[2]   DAPSONE SUPPRESSES INTEGRIN-MEDIATED NEUTROPHIL ADHERENCE FUNCTION [J].
BOOTH, SA ;
MOODY, CE ;
DAHL, MV ;
HERRON, MJ ;
NELSON, RD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (02) :135-140
[3]   Studies on the toxicity of analogues of dapsone in-vitro using rat, human and heterologously expressed metabolizing systems [J].
Coleman, MD ;
Smith, SN ;
Kelly, DE ;
Kelly, SL ;
Seydel, JK .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (09) :945-950
[4]   THE USE OF CIMETIDINE TO REDUCE DAPSONE-DEPENDENT METHEMOGLOBINEMIA IN DERMATITIS-HERPETIFORMIS PATIENTS [J].
COLEMAN, MD ;
RHODES, LE ;
SCOTT, AK ;
VERBOV, JL ;
FRIEDMANN, PS ;
BRECKENRIDGE, AM ;
PARK, BK .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (03) :244-249
[5]   BIOACTIVATION OF DAPSONE TO A CYTO-TOXIC METABOLITE BY HUMAN HEPATIC-MICROSOMAL ENZYMES [J].
COLEMAN, MD ;
BRECKENRIDGE, AM ;
PARK, BK .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (04) :389-395
[6]  
DEBOL SM, 1995, J INVEST DERMATOL, V104, P647
[7]  
ELASHOFF JD, 1981, GASTROENTEROLOGY, V80, P615
[8]  
HARVATH L, 1986, J IMMUNOL, V137, P1305
[9]   IMPROVED RAPID PHOTOMETRIC ASSAY FOR QUANTITATIVE MEASUREMENT OF PMN MIGRATION [J].
JUNGER, WG ;
CARDOZA, TA ;
LIU, FC ;
HOYT, DB ;
GOODWIN, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 160 (01) :73-79
[10]   SYNTHESIS OF NEW 2,4-DIAMINO-5-BENZYLPYRIMIDINES ACTIVE AGAINST VARIOUS BACTERIAL SPECIES [J].
KANSY, M ;
SEYDEL, JK ;
WIESE, M ;
HALLER, R .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1992, 27 (03) :237-244